Related Experiment Video
Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
TransGAT-DTA: A multi-task framework for drug-target affinity prediction and conditional molecule generation
Xiaorui Huang1, Xingyu Liu1, Maoyuan Zhou1
1Academy of Artificial Intelligence, Beijing Institute of Petrochemical Technology, Beijing, 102617, China.
Abstract:
Discovering novel molecules that effectively interact with target proteins remains a time-consuming and costly challenge in drug development. Current machine learning approaches are typically limited to single-task settings and cannot simultaneously address drug-target affinity prediction and targeted molecule generation. To overcome this limitation, we propose TransGAT-DTA, a multi-task learning framework that integrates a shared graph-Transformer architecture for molecular feature encoding with gated CNNs for hierarchical protein sequence representation. Cross-modal feature integration is achieved via a learnable alignment module, and a dynamic gradient coordination mechanism balances the regression objective for affinity prediction with the variational lower-bound optimization for molecule generation. Additionally, conditional control attention guides the model to generate molecules consistent with predicted target affinities. Experimental evaluation on benchmark datasets including BindingDB, Davis, and KIBA demonstrates that TransGAT-DTA reduces mean squared error in affinity prediction relative to single-task models, while simultaneously enabling the generation of high-quality, target-specific molecules. The end-to-end design mitigates error accumulation inherent in conventional cascaded approaches and provides a robust framework for bidirectional target-molecule optimization. These results establish a foundation for future applications in multi-target drug discovery.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...